← FDA Drug Approvals (Drugs@FDA)

ATAZANAVIR SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2014-04-22

Drug application

FDA Application #

ANDA091673

Application type

Abbreviated New Drug Application (Generic)

Brand name

ATAZANAVIR SULFATE

Generic name

ATAZANAVIR SULFATE

Active ingredients

ATAZANAVIR SULFATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2014-04-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown